Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 10, 2005, Pages 1283-1287

  Alexander, Russell T ^a,d   Lathrop, Sarah ^b   Vollmer, Robin ^c   Blue, Laura ^a   Russell, Stuart D ^a,e   Steenbergen, Charles ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d Milwaukee County Medical Examiner's Office   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOPSY; CARDIAC ALLOGRAFT VASCULOPATHY; CELL REJECTION; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY FIBROINTIMA HYPERPLASIA; FEMALE; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEAN ACUTE REJECTION SCORE; PAIR WISE T TEST; SCORING SYSTEM; STATISTICAL ANALYSIS; SURVIVAL;

ADOLESCENT; ADULT; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; FEMALE; FIBROMUSCULAR DYSPLASIA; GRAFT OCCLUSION, VASCULAR; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEART TRANSPLANTATION; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUNICA INTIMA;

EID: 26044446427     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hertz MI, Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report 2002. J Heart Lung Transplant. 2002;21:950-970.
2. Pahl E, Fricker FJ, Armitage J, et al. Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediatr. 1990;116: 177-183.
3. Graham AR. Autopsy findings in cardiac transplant patients: a 10-year experience. Am J Clin Pathol. 1992;97:369-375.
4. Rose AG, Viviers L, Odell JA. Autopsy-determined causes of death following cardiac transplantation: a study of 81 patients and literature review. Arch Pathol Lab Med. 1992;116:1137-1141.
5. Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Posttransplant coronary artery disease in children: a multicenter national survey. Circulation. 1994;90(5 pt 2): 1156-1160.
6. Sarris GE, Moore KA, Schroeder JS, et al. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg. 1994;108:240-251; discussion 251-252.
7. Sarris GE, Smith JA, Bernstein D, et al. Pediatric cardiac transplantation: the Stanford experience. Circulation. 1994;90(5 pt 2):II51-II55.
8. Alexander RT, Steenbergen C. Cause of death and sudden cardiac death after heart transplantation. Am J Clin Pathol. 2003;119:740-748.
9. Schütz A, Kemkes BM, Kugler C, et al. The influence of rejection episodes on the development of coronary artery disease after heart transplantation. Eur J Cardiothorac Surg. 1990;4:300-307.
10. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant. 1992;11:S38-S44.
11. Liu G, Butany J. Morphology of graft arteriosclerosis in cardiac transplant recipients. Hum Pathol. 1992;23:768-773.
12. Cary NR. Diagnostic criteria of chronic rejection in transplanted hearts. Transplant Proc. 1993;25:2026-2028.
13. Lin H, Wilson JE, Kendall TJ, et al. Comparable proximal and distal seventy of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human cardiac allografts. J Heart Lung Transplant. 1994;13:824-833.
14. Wong CK, Yeung AC. The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: influence of pre-existent donor atherosclerosis. J Heart Lung Transplant. 2001;20:858-864.
15. Uretsky BF, Murali S, Reddy S, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 1987;76:827-834.
16. Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation. 1989;80(5 pt 2):III100-III105.
17. Olivari MT, Romans DC, Wilson RF, Kubo SH, Ring WS. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. Circulation. 1989;80(5 pt 2):III111-III115.
18. McGiffin DC, Savunen T, Kirklin JK, et al. Cardiac transplant coronary artery disease: a multivariable analysis of pretransplantation risk factors for disease development and morbid events. J Thorac Cardiovasc Surg. 1995;109:1081-1088; discussion 1088-1089.
19. Dixon SR, Ruygrok PN, Agnew TM, et al. Cardiac allograft vasculopathy: the Green Lane Hospital experience 1987-1998. N Z Med J. 1999;12:417-420.
20. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation: rejection, infection, and coronary occlusive disease. Transplantation. 1991;52:244-252.
21. Costanzo-Nordin MR. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant. 1992;11(3 pt 2):S90-S103.
22. Rose EA, Pepino P, Barr ML, et al. Relationship of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant. 1992;11(3 pt 2):S120-S123.
23. ZerbeT, Uretsky B, Kormos R, et al. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 1992;11(3 pt 2):S104-S110.
24. Johnson MR. Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant. 1992;11(3 pt 2):S124-S132.
25. Everett JP, Hershberger RE, Norman DJ, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant. 1992;11(3 pt 2):S133-S137.
26. Mehra MR, Stapleton DD, Ventura HO, et al. Influence of donor and recipient gender on cardiac allograft vasculopathy: an intravascular ultrasound study. Circulation. 1994;90(5 pt 2):II78-II82.
27. Hauptman PJ, Nakagawa T, Tanaka H, Libby P. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease. J Heart Lung Transplant. 1995;14(6 pt 2):S173-S180.
28. Hosenpud JD, Everett JP, Morris TE, Mauck KA, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation. 1995;92:205-211.
29. Arbustini E, Dal Bello B, Morbini P, et al. Factors increasing the risk of allograft vascular disease in heart transplant recipients. C Ital Cardiol. 1997;27; 985-999.
30. Costanzo MR, Koch DM, Fisher SG, Heroux AL, Kao WG, Johnson MR. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant. 1997;16:169-178.
31. Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. J Heart Lung Transplant. 1997; 16:743-751.
32. Baan CC, Holweg CT, Niesters HG, et al. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation. J Heart Lung Transplant. 1998;17:363-373.
33. Higuchi ML, Benvenuti LA, Demarchi LM, Libby P. Histological evidence of concomitant intramyocardial and epicardial vasculitis in necropsied heart allografts: a possible relationship with graft coronary arteriosclerosis. Transplantation. 1999;67:1569-1576.
34. Qian Z, Hu W, Liu J, Sanfilippo F, Hruban RH, Baldwin WM. Accelerated graft atherosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries. Transplantation. 2001;72:900-906.
35. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med. 2003;349:847-858.
36. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group, The International Society for Heart Transplantation. J Heart Transplant. 1990;9:587-593.
37. Hornick P, Smith J, Pomerance A, et al. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant-associated coronary artery disease. Circulation. 1997;96(9 suppl):II148-II153.
38. Narrod J, Kormos R, Armitage J, Hardesty R, Ladowski J, Griffith B. Acute rejection and coronary artery disease in long term survivors of heart transplantation. J Heart Transplant. 1989;8:418-420.
39. Radovancevic B, Poindexter S, Birovljev S, et al. Risk factors for the development of accelerated coronary artery disease in cardiac transplant patients. Eur J Cardiothorac Surg. 1990;4:309-312.
40. Winters GL, Kendall TJ, Radio SJ, et al. Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant. 1990;4:364-371.
41. Winters GL, Johnson MR, Costanzo-Nordin MR. Prognostic significance of mild acute rejection [abstract]. Mod Pathol. 1991;4:22A.
42. Kobashigawa JA, Miller L, Yeung A, et al. Does acute rejection correlate with the development of transplant coronary artery disease? a multicenter study using intravascular ultrasound. J Heart Lung Transplant. 1995;14(6 pt 2):S221-S226.
43. Gao S, Schroeder JS, Hunt SA, Valantine HA, Hill IR, Stinson EB. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant. 1993;12:1029-1035.
44. Stovin PG, Sharpies L, Schofield PM, et al. Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease. J Heart Lung Transplant. 1993;12:110-116.
45. Billingham ME. The pathologic changes in long-term heart and lung transplant survivors. J Heart Lung Transplant. 1992;11(4 pt 2):S252-S257.
46. Dressler FA, Miller LW. Necropsy versus angiography: how accurate is angiography? J Heart Lung Transplant. 1992;11(4 pt 2):S56-S59.
47. Schroeder JS, Gao SZ, Hunt SA, Stinson EB. Accelerated graft coronary artery disease: diagnosis and prevention. J Heart Lung Transplant. 1992;11(4 pt 2):S258-S265.
48. Ventura HO, White CJ, Jain SP, et al. Assessment of intracoronary morphology in cardiac transplant recipients by angioscopy and intravascular ultrasound. Am J Cardiol. 1993;72:805-809.
49. Lowry RW, Kleiman NS, Raizner AE, Young JB. Is intravascular ultrasound better than quantitative coronary arteriography to assess cardiac allograft arteriopathy? Cathet Cardiovasc Diagn. 1994;31:110-115.
50. Rickenbacher PR, Pinto FJ, Chenzbraun A, et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol. 1995;25:171-177.